Dr. Charles (Charlie) Arnett prosecutes patent applications and manages global patent portfolios in the pharmaceutical and biotech industries. Charlie assists clients with a broad range of services, including preparation and prosecution of patent applications, management of worldwide patent portfolio strategies, performance of due diligence investigations, patentability and validity assessments, and freedom-to-operate analysis. Representative clients include Celgene Corporation, REGENXBIO, and Nuvalent.
Prior to joining Jones Day, Charlie was an NSF Graduate Research Fellow at the California Institute of Technology, where he synthesized and studied model complexes of the nitrogenase active site. He also contributed to the development of a Cu-catalyzed protocol for C-H etherification as an undergraduate at Georgetown University. Charlie has coauthored several peer-reviewed scientific publications, four of which are published in the Journal of the American Chemical Society.
- George Washington University (currently attending law school with expected graduation in 2025); California Institute of Technology (Ph.D. in Chemistry 2020; National Science Foundation [NSF] Graduate Research Fellowship); Georgetown University (B.S. in Chemistry 2015)
- Registered to practice before the U.S. Patent and Trademark Office